Braxia (BRAX.C) announces first multi-dose psilocybin trial in Canada Post date August 27, 2021 Posted by Piers Eaton Posted in brax.c, braxia, braxia scientific, CRTCE, Multi-Dose, Mushrooms, psilocybin, Psychedelics Comments 0
Braxia (BRAX.C) announces first multi-dose psilocybin trial in Canada Post date August 27, 2021 Posted by Piers Eaton Posted in brax.c, braxia, braxia scientific, CRTCE, Multi-Dose, Mushrooms, psilocybin, Psychedelics Comments 0
Braxia (BRAX.C) announces first multi-dose psilocybin trial in Canada Post date August 27, 2021 Posted by Piers Eaton Posted in brax.c, braxia, braxia scientific, CRTCE, Multi-Dose, Mushrooms, psilocybin, Psychedelics Comments 0
Braxia (BRAX.C) announces first multi-dose psilocybin trial in Canada Post date August 27, 2021 Posted by Piers Eaton Posted in brax.c, braxia, braxia scientific, CRTCE, Multi-Dose, Mushrooms, psilocybin, Psychedelics Comments 0
Braxia Scientific (BRAX.C) files Q4 and year-end financials, including big losses Post date July 30, 2021 Posted by Piers Eaton Posted in Big Losses, Biotech, braxia, braxia scientific, Eaton, financial statements, Health Science, Psychedelics, Rebranding, Scribes Comments 0